WO2023242827 - LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY

National phase entry:
Publication Number WO/2023/242827
Publication Date 21.12.2023
International Application No. PCT/IB2023/056294
International Filing Date 17.06.2023
Title **
[English] LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
[French] ADMINISTRATION OCULAIRE À BASE DE NANOPARTICULES LIPIDIQUES (LNP)
Applicants **
CRISPR THERAPEUTICS AG
Inventors
POLICE, Seshidhar Reddy
OUELLET, Dominique
LUKASON, Michael
DEQUEANT, Mary-Lee
Priority Data
63/353,374   17.06.2022   US
63/417,233   18.10.2022   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting4025
EPO Filing, Examination, Granting48107
Japan Filing, Examination, Granting3755
South Korea Filing, Examination, Granting5265
USA Filing, Examination, Granting14540
MasterCard Visa
Total: 75,692

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] ) gene in the trabecular meshwork cells of patients' eyes.[French] ) dans les cellules de réseau trabéculaire des yeux du patient.

Rejoining the server...